Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Interest Expenses (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Interest Expenses for 3 consecutive years, with -$2.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 443.86% year-over-year to -$2.7 million, compared with a TTM value of -$2.6 million through Sep 2025, down 218.65%, and an annual FY2024 reading of $28300.0, down 37.52% over the prior year.
  • Interest Expenses was -$2.7 million for Q3 2025 at SBC Medical Group Holdings, down from $1.1 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.7 million in Q1 2025 and bottomed at -$2.7 million in Q3 2025.
  • Average Interest Expenses over 3 years is -$51520.1, with a median of $654897.0 recorded in 2024.
  • Peak annual rise in Interest Expenses hit 120.05% in 2025, while the deepest fall reached 443.86% in 2025.
  • Year by year, Interest Expenses stood at -$535947.0 in 2023, then crashed by 407.17% to -$2.7 million in 2024, then dropped by 0.59% to -$2.7 million in 2025.
  • Business Quant data shows Interest Expenses for SBC at -$2.7 million in Q3 2025, $1.1 million in Q2 2025, and $1.7 million in Q1 2025.